Global Point-of-Care Molecular Diagnostics Market Share

Statistics for the 2023 & 2024 Global Point-of-Care Molecular Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Global Point-of-Care Molecular Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Point-of-Care Molecular Diagnostics Industry

The point-of-care molecular diagnostics market is consolidated. Global key players develop the majority of point-of-care molecular diagnostic tests. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-Pacific is witnessing the emergence of some small players due to the growing awareness, which has also helped the market to grow. Some of the major players include Abbott Laboratories, Bayer AG, Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Danaher Corporation, and BioMerieux.

Point of Care Molecular Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Danaher Corporation

  3. BioMerieux

  4. Bio-Rad Laboratories

  5. F. Hoffmann-La Roche Ltd

*Disclaimer: Major Players sorted in no particular order

"Abbott Laboratories,  F. Hoffmann-La Roche Ltd.,  Danaher Corporation,  BioMerieux,  Bio-Rad Laboratories"

Point of Care Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)